SpringWorks Therapeutics Inc (SWTX)
37.11
+0.81
(+2.23%)
USD |
NASDAQ |
Nov 22, 09:45
SpringWorks Therapeutics Gross Profit Margin (Quarterly): 93.22% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 93.22% |
| June 30, 2024 | 95.89% |
| Date | Value |
|---|---|
| March 31, 2024 | 94.28% |
| December 31, 2023 | 92.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
92.25%
Minimum
Dec 2023
95.89%
Maximum
Jun 2024
93.91%
Average
93.75%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ocugen Inc | -- |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.38% |
| Return on Assets | -44.72% |
| Return on Invested Capital | -51.38% |
| Profit Margin (Quarterly) | -108.6% |
| Operating Margin (Quarterly) | -117.5% |
| Return on Net Operating Assets | -569.7% |